MAPS 25th Anniversary Conference
Post-Conference Workshop
PSYCHEDELIC NEUROSCIENCE
with Matthew Baggott PhD & Nicholas Cozzi PhD
MONDAY, DECEMBER 12
9:00 AM-5:00 PM
Location TBA, Oakland Marriott City Center
CE & Psychedelic Education Program credit available
Workshop Program
Workshop leaders will present the latest advances in scientific understanding of how psychedelics affect the brain, in terms that are accurate yet accessible. Topics will include: DMT and its role in the brain, new views on the receptor interactions of psychedelic agents, mechanisms of psychedelic-induced visuals, what makes MDMA different from most other psychedelics, and up-to-date information on the potential harms and benefits of these fascinating compounds.
Workshop Participants
Matthew Baggott, Ph.D. is one of a small number of scientists in the world who administers psychedelics to healthy people in a laboratory setting in order to better understand how these substances affect consciousness. He earned his Ph.D. in Neuroscience from the University of California, Berkeley and is currently a postdoctoral fellow in Psychiatric Genetics at the University of Chicago. He has published in prestigious medical journals such as the New England Journal of Medicine and the Journal of the American Medical Association. He has written book chapters in Ecstasy: the Complete Guide and the Handbook of Neurotoxicology. You can find him online at http://gplus.to/mattbaggott or at http://www.psychedelicresearch.org.
Nicholas V. Cozzi, Ph.D. is a scientist and educator in the Department of Cell and Regenerative Biology at the University of Wisconsin School of Medicine and Public Health in Madison, WI. His background and training is in pharmacology, chemistry, and neuroscience. He holds a Ph.D. in Pharmacology and a B.S. in Pharmacology and Toxicology from the UW-Madison School of Pharmacy. Dr. Cozzi’s research interests include the design, synthesis, and mechanisms of action of substances with central nervous system activity. Compounds of special interest include tryptamines, phenylalkylamines, and lysergamides with psychedelic, antidepressant, and psychostimulant effects. As a neuroscientist, Dr. Cozzi is interested in how these drugs act in the brain to produce changes in consciousness, including spiritual or mystical experiences and changes in mood and cognition. Dr. Cozzi is a Pharmacology focus-area leader and instructor for courses taken by second-year medical students and Ph.D. students at the University of Wisconsin-Madison. Dr. Cozzi has won several teaching and research awards and is involved in shaping medical education policy at the UW. Outside the University, Dr. Cozzi consults for legal, pharmaceutical, and biotechnology clients.
CEs for psychologists are provided by The Spiritual Competency Resource Center (SCRC) which is co-sponsoring this program and is approved by the American Psychological Association to sponsor continuing education for psychologists. SCRC maintains responsibility for the program and its content. SCRC is a California Board of Registered Nursing Provider (BRN) and a Board of Behavioral Sciences Provider (BBS). For questions about CE, visit the SCRC website or contact David Lukoff, PhD at david.lukoff@gmail.com or 707-763-3576.